注4:基金引风险,投资须退储,详细基金法律文件及交易所,结算公司等相关业务规则, | 要包括信息技术、可选消费行 ने | -0. 2% | 22. 7倍 | 13.9% | | --- | --- | --- | --- | | 港股通消费ETF易方达 低费率 | | | 513070 | | 跟踪中证港股通消费主题指数 | | | | | 该指数由港股通范围内流动性 | 今日 | 该指数 | 该指数自2020年 | | 较好、市值较大的50只消费主 | 该指数涨跌 | 滚动市盈率 | 发布以来估值分位 | | 题股票组成,可选消费占比超 ୧୧% | 0. 1% | 18. 3倍 | 3. 3% | 注1:"读报教"指各上述基公产品具体测验的所数:敷招录(Ind,招致函数幅级正2076年2月25日收盘,滚球场盈率 估值分值超至2026年7月24日。流动市载率之地面/工近国个要度组属局公司股东的净利 球。球各组搭和中全身科家群相关。透得手段移动计算机受到更新时间的内容行业。68分国传奇陈像乃史上海市声追求能手游官网动员迷都的利用占比、估处分位很发利和时提宴。48分四区风力值费发布 日:49申储估值复复纪录日比 ...

Core Viewpoint - The Hong Kong stock market experienced fluctuations, with various indices showing declines, indicating a divergence in market performance among sectors, particularly between AI and internet giants, despite positive consumer data [1]. Group 1: Market Performance - The China Securities Hong Kong Stock Connect Consumer Theme Index fell by 1.3% [1] - The Hang Seng Technology Index decreased by 2.1% [1] - The Hang Seng Hong Kong Stock Connect New Economy Index dropped by 2.5% [1] - The China Securities Hong Kong Stock Connect Medical and Health Comprehensive Index declined by 3.1% [1] - The China Securities Hong Kong Stock Connect Internet Index fell by 3.3% [1] Group 2: Fund Flows - The net inflow for the E Fund Hang Seng Technology ETF (513010) reached 3.61 billion yuan in the last month [1] - The net inflow for the E Fund Hong Kong Stock Connect Internet ETF (513040) was 1.49 billion yuan in the last month [1] Group 3: Sector Insights - The report from Huatai Securities indicates increased market differentiation during the Spring Festival, with AI new forces and internet giants showing divergent trends [1] - Despite bright consumer data, there was no significant uplift in sector performance, with gains concentrated in technology and cyclical industries [1] - The short-term outlook suggests investors should be cautious of volatility risks associated with index adjustments and individual stock movements [1] - The mid-term strategy highlights technology and cyclical materials as clear main lines for investment [1]

Core Viewpoint - The pharmaceutical industry is experiencing growth due to persistent human demand and unmet needs, alongside increased R&D investments by companies, marking the transition to an "innovation-driven" revenue era in China [1]. Index Performance - The CSI Hong Kong Stock Connect Healthcare Comprehensive Index rose by 3.3% this week, while the Hang Seng Hong Kong Stock Connect Innovative Drug Index increased by 2.5%. Conversely, the CSI Innovative Drug Industry Index and the CSI Biotech Theme Index both declined by 0.2%, and the CSI 300 Healthcare Index fell by 0.6% [1][2]. - Year-to-date performance shows the CSI Hong Kong Stock Connect Healthcare Comprehensive Index up by 10.8%, while the CSI Innovative Drug Industry Index is down by 0.1% [7]. Valuation Metrics - The rolling P/E ratios for the indices are as follows: Hang Seng Hong Kong Stock Connect Innovative Drug Index at 55.6x, CSI Hong Kong Stock Connect Healthcare Comprehensive Index at 33.4x, CSI Innovative Drug Industry Index at 51.3x, CSI Biotech Theme Index at 54.1x, and CSI 300 Healthcare Index at 29.8x [2][6]. - As of July 2023, the valuation percentiles indicate that the Hang Seng Hong Kong Stock Connect Innovative Drug Index is at 53.0%, the CSI Hong Kong Stock Connect Healthcare Comprehensive Index at 75.2%, and the CSI Innovative Drug Industry Index at 61.5% [2]. Industry Trends - The pharmaceutical sector in China is becoming a significant player in global innovative drug development, with increasing enthusiasm for overseas licensing [1]. - The market is characterized by a focus on leading companies in innovative drug research, development, and production, with a concentration on healthcare industry stocks [3].

Core Viewpoint - The Hong Kong stock market experienced fluctuations this week, with pharmaceutical stocks leading the gains, while the technology sector showed mixed results. The healthcare index rose by 3.3%, and the new economy index increased by 1.0% [1]. Index Performance - The performance of various indices this week is as follows: - CSI Hong Kong Stock Connect Healthcare Index: +3.3% - Hang Seng Hong Kong Stock Connect New Economy Index: +1.0% - CSI Hong Kong Stock Connect Consumer Theme Index: +0.8% - Hang Seng Technology Index: +0.3% - CSI Hong Kong Stock Connect Internet Index: -0.1% [2][1]. - The net inflows for ETFs this week were: - Hang Seng Technology ETF: 910 million - Hong Kong Stock Connect Internet ETF: 250 million [1]. Future Outlook - According to Guotai Junan Securities, by 2026, AI applications are expected to evolve from usable to highly effective, with diverse business models emerging. AI applications are projected to become a core theme in the AI industry market, particularly for internet platform companies with high capital expenditure and mature products, as well as companies in healthcare, finance, and education sectors focusing on vertical product development [1].

速2) 银行. 互联网平台等给天得售机构提供可近外投资的ETP联盟基金。 | 跟踪中证港股通消费主题指数 | | | | | --- | --- | --- | --- | | 该指数由港股通范围内流动性 | 今日 | 该指数 | 该指数自2020年 | | 较好、市值较大的50只消费主 | 该指数涨跌 | 滚动市盈率 | 发布以来估值分位 | | 题股票组成,可选消费占比超 65% | -0. 5% | 18.6倍 | 4. 6% | 21)。"国语教"报告上达签会严语具体面积的领图。数据第四8000、份家建建和崛起》2004年2月11日收盘。国际资讯率：站值分位最近2000年7月10日，面积所退军公进做了正因个中度又属着尘动现象的变形 %、媒体值得在淘山企业具体漏客启关。进行于品特创动动放工工业局用影响较小的行业。组组分立刻信任做正史上海决推進事委于以前面动改属军的利润石烂。体强分位数表示和力管家、植性分位签同力质量发布 BI/4安倍借款量配足球33282920042月10日，借生用登通新处济南散发布分为2018年/月2日,可更滑值值之限分立707年41月21日起，但生科比假面直表任为7000年7月7日: ...

Group 1 - The Hang Seng Hong Kong Stock Connect Innovative Drug Index rose by 2.6%, while the China Securities Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index increased by 2.4% [1] - The China Securities Innovative Drug Industry Index and the China Securities Biotechnology Theme Index saw increases of 1.4% and 1.0% respectively, with the CSI 300 Pharmaceutical and Health Index rising by 0.9% [1] - Huachuang Securities stated that the fundamental reason for the pharmaceutical industry's ability to reach new highs despite ongoing challenges is the continuous demand for pharmaceuticals and the increasing number of unmet needs, along with pharmaceutical companies' ongoing investment in R&D to meet these demands [1] - China has become a significant player in global innovative drug R&D, with overseas licensing activity continuing to rise year after year, marking the pharmaceutical industry’s entry into a revenue era driven by innovation [1]

Core Viewpoint - The Hong Kong stock market shows resilience with various indices experiencing gains, indicating a stabilization in earnings expectations despite previous downward adjustments in EPS forecasts for the Hang Seng Technology Index [1]. Group 1: Index Performance - The CSI Hong Kong Stock Connect Healthcare Index rose by 2.4% [1] - The CSI Hong Kong Stock Connect Consumer Theme Index increased by 1.1% [1] - The Hang Seng Hong Kong Stock Connect New Economy Index gained 0.8% [1] - The Hang Seng Technology Index saw a rise of 0.6% [1] - The CSI Hong Kong Stock Connect Internet Index experienced a slight increase of 0.1% [1] Group 2: Fund Inflows - The E Fund Hang Seng Technology ETF (513010) has recorded over 3 billion yuan in net inflows for six consecutive trading days, totaling more than 20 billion yuan [1]. Group 3: Earnings Expectations - According to China Merchants Securities, the fundamentals of the Hong Kong stock market remain solid, with earnings expectations stabilizing [1]. - The EPS forecast for the Hang Seng Technology Index has been continuously adjusted downward since September but has now stabilized, suggesting that current stock prices reflect the market's phase of earnings revision [1].

Core Viewpoint - The pharmaceutical industry is experiencing growth due to persistent human demand and unmet needs, alongside increased R&D investments by companies, marking the transition to an "innovation-driven" revenue era in China [1]. Group 1: Index Performance - The CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index rose by 2.1% [1]. - The Hang Seng Hong Kong Stock Connect Innovative Drug Index increased by 2.0% [1]. - The CSI Biotechnology Theme Index saw a rise of 0.6% [1]. - The CSI Innovative Drug Industry Index grew by 0.4% [1]. - The CSI 300 Pharmaceutical and Health Index experienced a slight increase of 0.2% [1]. Group 2: Index Composition - The index focuses on leading innovative drug companies in A-shares, comprising no more than 50 stocks involved in innovative drug R&D [5]. - The index tracks leading biotechnology companies in A-shares, including no more than 50 stocks related to gene diagnostics, biopharmaceuticals, and other human biotechnology [7]. - The index covers leading companies in the pharmaceutical and health industry within the CSI 300, including segments like chemical pharmaceuticals, medical services, and medical devices [9]. Group 3: Valuation Metrics - The rolling P/E ratio for the innovative drug index is 50.4 times, with a valuation increase of 72.3% since its inception [6]. - The rolling P/E ratio for the biotechnology index is 53.2 times, with a valuation increase of 58.7% since its inception [8]. - The rolling P/E ratio for the CSI 300 Pharmaceutical and Health Index is 29.9 times, with a valuation increase of 39.2% since its inception [10].

Core Viewpoint - The Hong Kong stock market indices related to healthcare, consumer, and technology sectors have shown positive performance, with significant net inflows into related ETFs, indicating investor confidence in these sectors. Group 1: Index Performance - The CSI Hong Kong Stock Connect Healthcare Index increased by 2.1% [1] - The CSI Hong Kong Stock Connect Consumer Theme Index rose by 1.9% [1] - The CSI Hong Kong Stock Connect Internet Index saw a rise of 1.7% [1] - The Hang Seng Hong Kong Stock Connect New Economy Index increased by 1.5% [1] - The Hang Seng Technology Index rose by 1.3% [1] Group 2: ETF Inflows - The Hong Kong Stock Connect Internet ETF managed by E Fund (513040) experienced a net inflow of 600 million yuan last week [1] - The Hang Seng Technology ETF managed by E Fund (513010) saw a net inflow of 1.8 billion yuan last week [1] Group 3: ETF Details - The Hong Kong Stock Connect New Economy ETF (513320) tracks the Hang Seng Hong Kong Stock Connect New Economy Index, which consists of 50 large-cap stocks in the "new economy" sectors, with a rolling P/E ratio of 23.9 times and a valuation percentile of 47.5% since its inception in 2018 [2] - The Hang Seng Technology ETF (513010) tracks the Hang Seng Technology Index, comprising 30 large-cap stocks related to technology, with a rolling P/E ratio of 22.1 times and a valuation percentile of 23.1% since its launch in 2020 [2] - The Hong Kong Stock Connect Healthcare ETF (513200) tracks the CSI Hong Kong Stock Connect Healthcare Index, consisting of 50 liquid and large-cap stocks in the healthcare sector, with a rolling P/E ratio of 32.3 times and a valuation percentile of 51.2% since its inception in 2017 [2] - The Hong Kong Stock Connect Internet ETF (513040) tracks the CSI Hong Kong Stock Connect Internet Index, which includes 30 leading internet companies, with a rolling P/E ratio of 23.8 times and a valuation percentile of 19.5% since its launch in 2021 [2]

Group 1 - The Hang Seng Hong Kong Stock Connect New Economy Index increased by 1.0%, while the CSI Hong Kong Stock Connect Internet Index rose by 0.8%, the Hang Seng Technology Index by 0.5%, the CSI Hong Kong Stock Connect Consumer Theme Index by 0.3%, and the CSI Hong Kong Stock Connect Healthcare Comprehensive Index by 0.2% [1] - Dongwu Securities indicates that the Hong Kong stock market is in a trend of gradual upward movement, with AI applications expected to accelerate and the semiconductor industry entering a comprehensive price increase phase [1] - Southbound capital flow shows that the information technology sector is one of the main industries for net inflows in the Hong Kong Stock Connect, suggesting a dynamic focus on AI technology in market positioning [1] Group 2 - The E Fund Hong Kong Stock Connect New Economy ETF tracks the Hang Seng Hong Kong Stock Connect New Economy Index, which consists of 50 stocks from the "new economy" sector with the largest market capitalization [2] - The E Fund Hong Kong Stock Connect Technology ETF tracks the Hang Seng Technology Index, comprising 30 stocks highly related to technology, with over 90% of the index made up of information technology and consumer discretionary sectors [2] - The E Fund Hong Kong Stock Connect Healthcare ETF tracks the CSI Hong Kong Stock Connect Healthcare Comprehensive Index, consisting of 50 liquid and large-cap stocks in the healthcare sector, which accounts for over 90% of the index [2] - The E Fund Hong Kong Stock Connect Internet ETF tracks the CSI Hong Kong Stock Connect Internet Index, made up of 30 leading internet companies, primarily in information technology and consumer discretionary sectors [3]